LAXMIDENTL2024-10-012024-12-31 LAXMIDENTL2024-10-012024-12-31 LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member LAXMIDENTL2024-12-31 LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue01Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue02Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue03Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue01Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue02Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue03Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults01Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults02Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults03Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults01Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults02Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults03Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets01Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets02Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets03Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member LAXMIDENTL2024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member LAXMIDENTL2024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member LAXMIDENTL2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member LAXMIDENTL2024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 544339 LAXMIDENTL NA Laxmi Dental Limited Equity 2024-04-01 2025-03-31 2025-02-13 2025-02-07 INR Millions Third quarter 15:00:00 21:15:00 2025-02-13 2025-02-13 Not applicable Multi segment 2024-10-01 2024-12-31 Unaudited Consolidated 616600000.00 5860000.00 622460000.00 68830000.00 77300000.00 14810000.00 217620000.00 15350000.00 39530000.00 141900000.00 575340000.00 47120000.00 0.00 47120000.00 3350000.00 7350000.00 10700000.00 0.00 36420000.00 0.00 0.00 0.00 11750000.00 48170000.00 490000.00 48660000.00 48000000.00 170000.00 490000.00 0.00 103480000.00 2 0.88 0.88 0.00 0.00 0.88 0.88 0.00 0.00 0.00 Multi segment 2024-04-01 2024-12-31 Unaudited Consolidated 1784400000.00 17070000.00 1801470000.00 331220000.00 102070000.00 10200000.00 601010000.00 41330000.00 107210000.00 416400000.00 1609440000.00 192030000.00 66170000.00 258200000.00 13070000.00 26690000.00 39760000.00 0.00 218440000.00 -8090000.00 -1000000.00 -7090000.00 64260000.00 275610000.00 260000.00 275870000.00 274910000.00 700000.00 260000.00 0.00 103480000.00 2 5.16 5.16 -0.13 -0.13 5.03 5.03 0.00 0.00 0.00 Other Expenses 141900000.00 Other Expenses 416400000.00 Aligners Business 236510000.00 Laborartory Business 444870000.00 Other Business 32520000.00 Aligners Business 652820000.00 Laborartory Business 1278010000.00 Other Business 102160000.00 713900000.00 2032990000.00 97300000.00 248580000.00 616600000.00 1784410000.00 Aligners Business 37450000.00 Laborartory Business 51180000.00 Other Business 4300000.00 Aligners Business 125450000.00 Laborartory Business 174690000.00 Other Business 9680000.00 92930000.00 309820000.00 15360000.00 41330000.00 30430000.00 Segment assets and liabilities: The CODM does not monitor operating assets used by the operating segment. Therefore, disclosures of segment assets, liabilities and capital expenditure have not been given. 6. During the quarter, the Board of Directors and Shareholders of the Company has approved the Employee Stock Option Plan 2024 (“ESOP 2024”) for the employees of the Company and its subsidiary companies comprising of equity shares of the Company, not exceeding 5,00,000 equity shares of face value of Rs. 2/- each from which the total number of options granted was 351, 672 equity shares of face value of Rs. 2/- each on December 14, 2024. 7, During the quarter ended December 31, 2024, the Company has converted the 0.0001% Compulsorily Convertible Preference Shares (CCPS) aggregating to 290,597 preference shares of par value of Rs. 400 each converted to 23,930,663 Equity Shares of Rs. 2 each. 8. On May 07, 2024, the Company sold one of its Investment properties at the sale consideration of Rs. 101 million. The book value of the aforesaid Property as on the date of sale was Rs. 7.10 million. The Company accounted for difference between the sale consideration and book value as gain on sale of Investment property Rs. 66.17 million (net of tax Rs. 27.73 million) as an exceptional gain. During the previous year, the group has recognised the loss of Rs. 0.85 millions as an exceptional items on dissolution of subsidiary Techlab Consulting LLP. 9. During the period ended December 31, 2024, the Company split its 309,060 equity shares of face value of Rs.10 each to 1,545,300 Equity Shares of face value of Rs.2 each. Further, on approval of the Board of Directors and Shareholders, the company issued 26,270,100 bonus shares (17:1) face value of Rs. 2 each, by capitalizing the free reserves. Basic and Diluted EPS disclosed after considering effect of bonus and split equity shares issued. 10. Subsequent to the quarter and nine month ended December 31, 2024, the Company has completed an Initial Public Offer of 16,309,766 equity shares of face value of Rs. 2/- each comprising of (i) fresh issue of 3,224,299 equity shares at an issue price of Rs. 428 per equity share aggregating to Rs. 1,380 million, and (ii) an offer for sale of 13,085,467 equity shares at an issue price of Rs. 428 per equity share aggregating to Rs. 5,600.58 million and listed on both Bombay Stock Exchange Limited (BSE) and National Stock Exchange (NSE) on January 20, 2025. 11. The above unaudited consolidated financial results of the Company are available on the Company's website (www.laxmidentallimited.com/) and stock exchanges websites, BSE (www.bseindia.com) and NSE (www.nseindia.com), where the shares of the Company are listed. 76460000.00 47140000.00 192030000.00 Aligners Business 0.00 Laborartory Business 0.00 Other Business 0.00 0.00 Aligners Business 0.00 Laborartory Business 0.00 Other Business 0.00 0.00 810000.00 -80000.00 0.00 0.00 320000.00 -340000.00